Traitement médical de l’endométriose

In: Côlon & Rectum · 2016 · vol. 10(3) , pp. 164–166 · doi:10.1007/s11725-016-0660-4 · W2488791840
article OA: closed CC0 ⤵ 1 in-corpus citation
Full text JSON View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-08

Medical treatment of endometriosis, primarily hormonal therapy aiming for hypoestrogenism, is increasingly used for surgical preparation and recurrence prevention, with oral contraceptives and progestins offering longer-term options than GnRH agonists.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-08 · read from full text

This paper reviews the role of medical treatment in endometriosis, focusing on how hormone therapy is used alongside or around surgical management. It describes hormonal strategies aimed at inducing hypoestrogenism, noting that GnRH agonists are prescribed for limited durations, while combined estrogen-progestin pills and progestins can be used for longer periods, particularly for recurrence prevention after surgery. The key emphasis is that curative care remains largely surgical, with medical therapy increasingly positioned to reduce recurrence risk and support a less aggressive overall approach. This paper is centrally about endometriosis — it specifically addresses medical (hormonal) treatment strategies for symptom control and prevention of recurrences.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

L’endométriose est une affection fréquente dont les symptômes peuvent être variés. Le traitement curatif repose surtout sur l’approche opératoire, mais le traitement médical prend une place croissante dans la préparation à la chirurgie et surtout dans la prévention des récidives. La base du traitement est l’hormonothérapie dont l’objectif est d’obtenir une hypo-oestrogénie. Si les agonistes de la GnRH sont prescrits de façon limitée dans le temps, les pilules oestroprogestatives et les progestatifs pourront être administrés beaucoup plus longtemps.
Full text 4,028 characters · extracted from oa-doi-fallback · click to expand
Résumé L’endométriose est une affection fréquente dont les symptômes peuvent être variés. Le traitement curatif repose surtout sur l’approche opératoire, mais le traitement médical prend une place croissante dans la préparation à la chirurgie et surtout dans la prévention des récidives. La base du traitement est l’hormonothérapie dont l’objectif est d’obtenir une hypo-oestrogénie. Si les agonistes de la GnRH sont prescrits de façon limitée dans le temps, les pilules oestroprogestatives et les progestatifs pourront être administrés beaucoup plus longtemps. Abstract Endometriosis is a common condition with various symptoms. The curative treatment is usually associated to surgical approach. The aim of medical treatment is to avoid recurrences and, in association to surgery, offer the patient a limited and less aggressive approach. GnRH agonists can be used for limited duration. Progestatives can be administered for a longer period to prevent recurrences. Références Guo SW (2009) Recurrence of endometriosis and its control. Hum Reprod Update 15:441–61 Vercellini P, Somigliana E, Vigano P, et al (2009) The effect of second-line surgery on reproductive performance of women with recurrent endometriosis: a systematic review. Acta Obstet Gynecol Scand 88:1074–82 Koga K, Osuga Y, Takemura Y, et al (2013) Recurrence of endometrioma after laparoscopic excision and its prevention by medical management. Front Biosci (Elite Ed) 5:676–83 Somigliana E, Vercellini P, Vigano P, et al (2014) Postoperative medical therapy after surgical treatment of endometriosis: from adjuvant therapy to tertiary prevention. J Minim Invasive Gynecol 21:328–34 Vercellini P, Frontino G, De Giorgi O, et al (2003) Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil Steril 80:560–3 Seracchioli R, Mabrouk M, Manuzzi L, et al (2009) Postoperative use of oral contraceptive pills for prevention of anatomical relapse or symptom-recurrence after conservative surgery for endometriosis. Hum Reprod 24:2729–35 Roman H (2007) [Guidelines for the management of painful endometriosis]. J Gynecol Obstet Biol Reprod (Paris) 36:141–50 Donnez J, Nisolle M, Grandjean P, et al (1992) The place of GnRH agonists in the treatment of endometriosis and fibroids by advanced endoscopic techniques. Br J Obstet Gynaecol 99 (Suppl 7):31–3 Redwine DB (1991) Conservative laparoscopic excision of endometriosis by sharp dissection: life table analysis of reoperation and persistent or recurrent disease. Fertil Steril 56:628–34 Dubernard G, Piketty M, Rouzier R, et al (2006) Quality of life after laparoscopic colorectal resection for endometriosis. Hum Reprod 21:1243–7 Jones KD, Haines P, Sutton CJ (2001) Long-term follow-up of a controlled trial of laser laparoscopy for pelvic pain. JSLS 5:111–5 Giudice LC (2010) Clinical practice. Endometriosis. N Engl J Med 362:2389–98 Angioni S, Pontis A, Dessole M, et al (2015) Pain control and quality of life after laparoscopic en-block resection of deep infiltrating endometriosis (DIE) vs. incomplete surgical treatment with or without GnRHa administration after surgery. Arch Gynecol Obstet 291:363–70 Vercellini P, Crosignani PG, Abbiati A, et al (2009) The effect of surgery for symptomatic endometriosis: the other side of the story. Hum Reprod Update 15:177–88 Roman H, Vassilieff M, Gourcerol G, et al (2011) Surgical management of deep infiltrating endometriosis of the rectum: pleading for a symptom-guided approach. Hum Reprod 26:274–81 Somigliana E, Vercellini P, Daguati R, et al (2010) Effect of delaying post-operative conception after conservative surgery for endometriosis. Reprod Biomed Online 20:410–5 Author information Authors and Affiliations Corresponding author About this article Cite this article Ploteau, S. Traitement médical de l’endométriose. Colon Rectum 10, 164–166 (2016). https://doi.org/10.1007/s11725-016-0660-4 Published: Issue date: DOI: https://doi.org/10.1007/s11725-016-0660-4

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (16)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK